Effect of lamivudine in HBeAg-positive chronic hepatitis B: discordant effect on HBeAg and HBV DNA according to pretreatment ALT level

about

Effect of lamivudine in HBeAg-positive chronic hepatitis B: discordant effect on HBeAg and HBV DNA according to pretreatment ALT level

Item

http://www.wikidata.org/entity/Q35045329

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Effect of lamivudine in HBeAg- ...... ding to pretreatment ALT level

@en

type

Item

label

Effect of lamivudine in HBeAg- ...... ding to pretreatment ALT level

@en

prefLabel

Effect of lamivudine in HBeAg- ...... ding to pretreatment ALT level

@en

P1476

Effect of lamivudine in HBeAg- ...... ding to pretreatment ALT level

@en

P2093

Fumio Imazeki

http://www.w3.org/2001/XMLSchema#string

Hiromitsu Saisho

http://www.w3.org/2001/XMLSchema#string

Kenichi Fukai

http://www.w3.org/2001/XMLSchema#string

Osamu Yokosuka

http://www.w3.org/2001/XMLSchema#string

Shigenobu Kawai

http://www.w3.org/2001/XMLSchema#string

Tatsuo Kanda

http://www.w3.org/2001/XMLSchema#string

Tomoko Kurihara

http://www.w3.org/2001/XMLSchema#string

P2860

Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.

Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay.

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.

Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences.

Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.

P304

3346-3350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I22.3346

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273181256

http://www.w3.org/2001/XMLSchema#string

P698

15948237

http://www.w3.org/2001/XMLSchema#string

P932

4315986

http://www.w3.org/2001/XMLSchema#string